Posted on 1/13/21
Flexion Therapeutics Announces Preliminary, Unaudited Fourth-Quarter and Full-Year 2020 Results
BURLINGTON, Mass., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced preliminary and unaudited net sales for the fourth quarter and full year . . .
Posted on 1/13/21
Moderna and Uber Teaming Up on Coronavirus Vaccine Awareness Push
In an unusual business tie-up, biotech Moderna (NASDAQ:MRNA) and ridesharing king Uber Technologies (NYSE:UBER) are collaborating on a program to raise awareness of coronavirus vaccines.According to . . .
Posted on 1/13/21
Cullinan Management Closes of IPO
CAMBRIDGE, Mass., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Cullinan Management, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology and . . .
Posted on 1/12/21
Turner Imaging Systems Collaborate with Massachusetts General Hospital
OREM, Utah--(BUSINESS WIRE)--Turner Imaging Systems, developers of the revolutionary Smart-C X-ray imaging system, has entered into a Sponsored Research Project with Massachusetts General Hospital to investigate . . .
Posted on 1/12/21
Vedanta Biosciences Announces $25 Million Investment from Pfizer
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta Biosciences, a leading clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally defined consortia of human microbiome-derived bacteria, . . .
Posted on 1/12/21
StretchMed Opens in Winchester
The newest health and wellness offering has opened in Winchester Center to help alleviate chronic pain, reduce stress, increase mobility, rejuvenate, and help you move well . . .
Posted on 1/12/21
Generation Bio Closes of Public Offering
CAMBRIDGE, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of gene therapy, today . . .
Posted on 1/12/21
EyePoint Pharmaceuticals Provides Business Update
WATERTOWN, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products provided a . . .
Posted on 1/12/21
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological . . .
Posted on 1/12/21
Vedanta Biosciences Announces $25 Million Investment from Pfizer
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta Biosciences, a leading clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally defined consortia of human microbiome-derived bacteria, . . .
Posted on 1/12/21
Aileron Therapeutics Announces Completion of $35.9 Million Registered Direct Offering
WATERTOWN, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Aileron Therapeutics, Inc. (Nasdaq: ALRN) today announced the completion of its previously announced registered direct offering of 32,630,983 . . .
Posted on 1/12/21
Moderna Launches 3 New Vaccine Programs Beyond Coronavirus
Moderna (NASDAQ:MRNA) has become known for its coronavirus vaccine that's recently been authorized by multiple regulatory agencies. But the biotech's underlying messenger RNA (mRNA) technology can . . .
Posted on 1/12/21
Deciphera Pharmaceuticals Provides Corporate Update
WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a commercial-stage biopharmaceutical company developing innovative medicines to improve the lives of people with cancer, today provided a corporate update . . .
Posted on 1/12/21
Moderna Provides Business Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it is expanding its pipeline of innovative . . .
Posted on 1/12/21
Scholar Rock Provides Corporate Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, . . .
Posted on 1/12/21
Sensei Biotherapeutics Announces $30 Million Financing
BOSTON & ROCKVILLE, Md.--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc., a clinical-stage cancer immunotherapy company, today announced the successful closing of a $30 million Series B financing. The financing . . .
Posted on 1/11/21
My Best Biotech Stock for 2021
It's only been a couple of years since BridgeBio Pharma (NASDAQ:BBIO) made its stock market debut, and the company already has two new drug applications under . . .
Posted on 1/11/21
Tekla World Healthcare Fund Authorizes a Rights Offering
BOSTON--(BUSINESS WIRE)--On January 7, 2021, the Board of Trustees of Tekla World Healthcare Fund authorized the filing of a preliminary registration statement with the Securities and Exchange . . .
Posted on 1/11/21
Alnylam Launches “Alnylam P5x25” Strategy for Planned Transition to a Top Five Biotech in Market Capitalization
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced its new 5-year strategy “Alnylam P5x25” focused on the Company’s planned transition . . .
Posted on 1/8/21
Carrum Health Raises $40M in Series A Funding
Carrum Health, a San Francisco, CA-based digital health company connecting employers and employees to Centers of Excellence (COEs) through a technology-powered platform, closed a $40m Series . . .
Posted on 1/8/21
Hologic Announces Preliminary Financial Results for First Quarter of Fiscal 2021
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today preliminary revenue results for its first fiscal quarter ended December 26, 2020.The Company expects to report total revenues . . .
Posted on 1/8/21
MANA Therapeutics Launches with $35 Million Series A Financing
WALTHAM, Mass.--(BUSINESS WIRE)--MANA Therapeutics, a clinical-stage company creating nonengineered, off-the-shelf allogeneic cell therapies that target multiple cancer antigens, today announced a $35 million Series A financing. . . .
Posted on 1/8/21
Moderna CEO Says Its Coronavirus Vaccine Could Be Effective for Years
It's possible that two jabs of Moderna's (NASDAQ:MRNA) recently authorized coronavirus vaccine will be sufficient for long-term protection against the global health scourge. On Thursday, the . . .
Posted on 1/8/21
Cullinan Management Prices of Upsized IPO
CAMBRIDGE, Mass., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Cullinan Management, Inc., a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with . . .
Posted on 1/7/21
Wellness Workdays and OccMed Consulting & Injury Care Offer COVID-19 Testing Services to Facilitate Businesses Return to Work Safely
Wellness Workdays, a leading provider of corporate wellness programs, and OccMed Consulting & Injury Care, , are offering employers customized testing solutions to prevent widespread business . . .
Boston
